Emergent Biosolutions Inc. buy Benchmark Co.
Start price
11.04.24
/
50%
€2.04
Target price
11.04.25
€4.65
Performance (%)
114.66%
Price
24.05.24
€4.38
Summary
This prediction is currently active. With a performance of 114.66% the BUY prediction by Benchmark_Co_ is a big success. This prediction currently runs until 11.04.25. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Emergent Biosolutions Inc. | -14.305% | -14.305% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by Benchmark_Co_ for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Ratings data for EBS provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Emergent Biosolutions Inc.
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€2.53
07.03.24
07.03.24
€4.58
07.03.25
07.03.25
73.36%
24.05.24
24.05.24
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€11.36
10.04.23
10.04.23
€20.27
10.04.24
10.04.24
-82.04%
11.04.24
11.04.24